Hawaii 2023 Regular Session

Hawaii Senate Bill SB983

Introduced
1/20/23  

Caption

Relating To Controlled Substances.

Impact

One notable consequence of SB983 is the enforcement of distance requirements for methadone clinics. The bill mandates that these facilities cannot be located within seven hundred fifty feet of a school, which is intended to address community concerns about the presence of substance treatment facilities near educational institutions. Clinics already in operation prior to the bill's enactment will be granted a one-year grace period to comply with the new distance requirement and registration stipulations, thereby allowing existing operations a chance to adjust.

Summary

Senate Bill 983 proposes amendments to the Hawaii Revised Statutes regarding the registration of clinics that handle controlled substances, specifically focusing on methadone treatment facilities. The bill stipulates that such clinics must maintain centralized ordering, storage, and record keeping, with provisions mandating that every location registering for a clinic must adhere to specific regulatory practices. This includes measures to ensure that controlled substances are handled responsibly, with proper documentation and professional supervision of dispensations to patients.

Contention

Debate surrounding the bill may stem from differing opinions on the effectiveness of imposing location restrictions on methadone clinics. Proponents argue that the distance requirement enhances community safety and decreases potential drug-related incidents near schools. Conversely, critics question whether such restrictions could adversely affect accessibility for those in need of treatment, potentially making it more challenging for individuals requiring methadone therapy to access these necessary services. As the bill aims to tighten regulations surrounding opioid treatment, it reflects ongoing concerns about substance abuse management within the state.

Companion Bills

HI HB378

Same As Relating To Controlled Substances.

Similar Bills

AZ HB2291

Opioids; containers; labeling; requirements; repeal

AZ HB2434

controlled substances prescription monitoring program

MS HB956

Opioid drugs; prescriber shall discuss with patient before prescribing, the risks of the drugs and available alternatives.

RI S3259

Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements and revises the uniform controlled substances act in accordance with current standards of professional practice.

RI H7923

Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements and revise the uniform controlled substances act in accordance with current standards of professional practice.

RI H5615

Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements, revises the uniform controlled substances act in accordance with current standards of professional practice and would repeal chapter 37.4 of title 5.

UT SB0113

Medical Prescription Amendments

IN SB0262

INSPECT program.